Key Developments: Omnicare Inc (OCR)
46.23USD
17 May 2013
$0.54 (+1.18%)
$45.69
$45.73
$46.28
$45.67
792,432
1,158,866
$46.28
$29.24
Latest Key Developments (Source: Significant Developments)
Omnicare Inc Reaffirms FY 2013 Guidance-Conference Call
Omnicare Inc announced that its management has reaffirmed fiscal 2013 revenue guidance of $6.1-6.2 billion and cash diluted EPS guidance of $3.47-3.57. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $6.1 billion and EPS of $3.54 for fiscal 2013. Full Article
Omnicare Inc Issues FY 2013 Guidance In Line With Analysts' Estimates-Conference Call
Omnicare Inc announced that for fiscal 2013, it expects revenues to be in the range of $6.1-$6.2 billion and adjusted cash based diluted earnings per share (EPS) to be in the range of $3.47-$3.57. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $6.19 billion and EPS of $3.53 for fiscal 2013. Full Article
Omnicare Inc Approves Quarterly Cash Dividend
Omnicare Inc announced that its Board of Directors approved a quarterly cash dividend of $0.14 per share on its common stock. The dividend is payable on March 22, 2013 to stockholders of record on March 7, 2013. Full Article
Omnicare Inc Raises FY 2012 EPS Guidance-Conference Call
Omnicare Inc raised fiscal 2012 guidance for adjusted cash earnings per share (EPS). Adjusted cash-based EPS per diluted share is now at $3.30 to $3.36, up from revised $3.22 to $3.28 and original $3.10 to $3.20 guidance. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $3.30 for fiscal 2012. Full Article
Omnicare Inc Announces Management Change; Increases Quarterly Cash Dividend; Approves Additional $350 Million In Share Repurchases
Omnicare Inc announced that it has named John L. Workman as its new chief executive Officer(CEO), effective immediately. Mr. Workman succeeded John Figueroa who resigned from the post he had held for 17 months. Separately, Omnicare announced it has approved an additional $350 million in share repurchases, which brings its total buyback authorization to $498 million. It also increased its quarterly cash dividend by 100% to $0.14 a share. The dividend increase is expected to cost Omnicare an additional $31.2 million a year. The Company also announced it has appointed Chief Operating Officer Nitin Sahney to the additional role of president and promoted Robert Kraft from senior vice president of finance to Chief Financial Officer. Both appointments are effective immediately. Full Article
Five Star Quality Care Inc Announces Completion Of Pharmacy Sale To Omnicare, Inc
Five Star Quality Care Inc announced that it has completed its previously announced sale of its pharmacy business to Omnicare, Inc. Five Star received $30.5 million in sale proceeds from Omnicare. In addition, Five Star sold to Omnicare, or retained, certain items of net working capital invested in its pharmacy business which, based on June 30, 2012 amounts, is approximately $8.2 million. Accordingly, Five Star currently expects to receive a total of $38.7 million (before transaction costs) in net cash receipts resulting from the sale and to record a capital gain of approximately $23.3 million. The pharmacy business that Five Star sold includes eight licensed pharmacies operating in 13 states that provide institutional pharmacy services to 247 senior living communities with approximately 12,300 living units. Full Article
Omnicare Inc Reaffirms FY 2012 Revenue Guidance; Raises FY 2012 EPS Guidance-Conference Call
Omnicare Inc announced that for fiscal 2012, it expects revenue to be between $6.1 billion-$6.2 billion compared to previous guidance of between $6.1 billion-$6.2 billion and adjusted cash earnings per diluted share (EPS) $3.22-$3.28 compared to previous guidance of between $3.10-$3.20. Full Article
Five Star Quality Care Inc Announces Agreement to Sell Pharmacy Business to Omnicare Inc
Five Star Quality Care Inc announced that it has entered into an agreement to sell its pharmacy business to Omnicare Inc for $30.7 million. Five Star anticipates the sale of this business will result in a capital gain to Five Star of approximately $23.5 million. Full Article
Omnicare Inc Reaffirms FY 2012 Guidance
Omnicare Inc announced that for fiscal 2012, it expects revenue to be in the range of $6.1 billion to $6.2 billion and adjusted cash-based income per diluted share (EPS) from continuing operations of $3.10 to $3.20, excluding special items. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $3.18 for fiscal 2012. Full Article
Omnicare Inc Settles DoJ Probe For $50 Million-Reuters
Reuters reported that Omniicare Inc said it will pay $50 million to settle an investigation by the U.S. Department of Justice (DoJ) concerning errors in the Company's distribution of controlled substances. Controlled substances are those whose distribution is strictly regulated by law because of their potential for abuse. Omnicare also said that the civil settlement released the Company's wholly owned and joint venture long term care pharmacies from all civil penalty claims by the DoJ's Drug Enforcement Administration related to the investigation. "The settlement contains no allegation or finding that any controlled substances were unlawfully diverted from the intended patient or that any patient was harmed". Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
